Analyst Ratings for Amphastar Pharmaceuticals Inc. (AMPH)

Updated: 2017-07-28

Analysts covering Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) have given it a consensus rating of Buy. Last month, AMPH received an average rating of Buy.

Of the 6 analysts covering the stock, 4 gave it a buy rating, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for AMPH. The most optimistic price target was 22, implying a possible profit of 27.24 percent. The most pessimistic price target was 16, implying potential capital losses of -7.46 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -13.39 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -22.11 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of AMPH to grow at a rate of 30.84 percent. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. AMPH has a PEG ratio of 2.95.

In the last 52-weeks, AMPH has achieved a high of 21.75 and a low of 12.05. Today's price is 43.49 percent above the 52-week low, and 20.51 percent lower than its 52-week high. AMPH has a price/earnings ratio of 91. Investors typically compare the P/E ratio to a company's peers in the industry. The AMPH value stock report compares AMPH to some of its peers using value stock charts. The market cap of AMPH is $0.8059 billion. AMPH's next earnings release will be on 0000-00-00, which is days away.